• Contact Us

    Immunization Branch
    Central Office
    1100 West 49th Street
    Austin, Texas 78756

    Phone: (800) 252-9152
    Fax: (512) 776-7288

    TVFC Provider Enrollment Fax: (512) 776-7743

National Immunization Survey (NIS)

On this page:   National Immunization Survey (NIS) 2014, Texas   |   NIS-Teen 2014, Texas   

National Immunization Survey (NIS) 2014, Texas

Immunization coverage among Texas children aged 19-35 months
Source: CDC NIS Tables

In this section:   NIS Background   |   NIS Table   |   NIS Graph   

◆ NIS Background

What is the National Immunization Survey (NIS)?
The NIS is a national survey conducted annually by the Centers for Disease Control and Prevention to assess immunization levels among pre-school children 19 through 35 months old. The NIS is the only population-based survey to provide national, state, local area, and territorial estimates of vaccination coverage among children aged 19–35 months in the United States. The NIS uses a quarterly, random-digit–dialed cellular and landline telephone number, followed by a mail survey of the children’s vaccination providers, to collect provider-confirmed vaccination information. Data are weighted to be representative of the population of children 19-35 months of age, and are adjusted for multiple phone lines, mixed telephone lines (i.e., landline and cellular), household nonresponse, and the exclusion of phoneless households. There is another survey, called the NIS-Teen, which assesses immunization levels among teens 13-17 years of age.

What is the importance of the NIS?
The NIS provides national and state estimates of vaccination coverage, including new vaccines as they are licensed and recommended for use. The survey also tracks progress towards Healthy People 2020 goals. The 2014 NIS is a measure of the effectiveness of strategies and activities that were in place up to three years ago.

What children were included in the 2014 NIS data?
The survey assessed the immunization histories of approximately 15,000 children in the United States, aged 19 through 35 months with provider-reported vaccination records. These children were born January 2011 through May 2013.

How is vaccine coverage defined?
As in 2013, the 4:3:1:3:3:1:4 series was reported which includes the full Hib vaccine. The 4:3:1:3:3:1:4 series is an overall measure that encompasses many vaccines that are recommended for children.

The 4:3:1:3:3:1:4 series includes the following vaccines:

  • 4 doses of diphtheria-tetanus-pertussis (DTaP);
  • 3 doses of Polio;
  • 1 dose of measles-mumps-rubella (MMR);
  • 3 or 4 doses of Hib depending on the product;
  • 3 doses of hepatitis B;
  • 1 dose of varicella; and
  • 4 doses of pneumococcal conjugate vaccine (PCV).

The 2014 NIS also focuses on the more recently recommended vaccines (i.e., hepatitis B vaccine birth dose, hepatitis A vaccine, PCV, and rotavirus vaccine) for children aged 19–35 months.

◆ NIS Table

Vaccination Coverage Levels in Texas and US - NIS

Vaccine

Texas 2013

Texas 2014

2013 to 2014
Texas Change
(+/-)

U.S. National
Average 2014

Hepatitis A

64.2%

61.2%

-3.0

57.5%

Varicella

93.6%

89.9%

-3.7

91.0%

Hepatitis B birth dose

81.8%

77.4%

-4.4

72.4%

3 Doses of Hepatitis B

89.5%

86.5%

-3.0

91.6%

MMR

92.7%

90.4%

-2.3

91.5%

Rotavirus

73.8%

68.5%

-5.3

71.7%

Pneumococcal

82.8%

78.6%

-4.2

82.9%

Hib

82.1%

76.2%

-5.9

82.0%

4 doses of DTaP

81.5%

78.2%

-3.3

84.2%

Polio

91.3%

90.4%

-0.9

93.3%

4:3:1:3:3:1:4 series

72.5%

64.0%

-8.5

71.6%

◆ NIS Graph

NIS2014


▲ Back to Top


NIS-Teen 2014, Texas

Immunization coverage among Texas teens 13-17 years old
Source: CDC NIS-Teen Tables

In this section:   NIS-Teen Background   |   NIS-Teen Table   |   NIS-Teen Graph   

◆ NIS-Teen Background

What is the National Immunization Survey-Teen (NIS-Teen)?
The NIS-Teen is a national survey conducted annually by the CDC to assess immunization levels for adolescents 13-17 years of age. This study collects data by interviewing households in all 50 States, the District of Columbia, and selected areas for oversampling. The interviews are conducted by telephone, with households selected at random. To ensure the accuracy and precision of the vaccination coverage estimates, immunization data for surveyed adolescents are also collected through a mail survey of their pediatricians, family physicians, and other health care providers. The parents and guardians of eligible adolescents are asked during the telephone interview for consent to contact the adolescents’ vaccination providers. Types of immunizations, dates of administration, and additional data about facility characteristics are requested from immunization providers that are identified during the telephone survey of households. The NIS-Teen’s estimates of adolescent vaccination coverage reflect a comparison of information provided by both surveyed households and immunization providers. There is another survey, called the NIS, that assesses immunization levels among children 19-35 months of age.

What is the importance of the NIS-Teen?
The NIS-Teen was established to provide an on-going, consistent data set for analyzing vaccination levels among adolescents in the United States (US) and to disseminate this information to interested public health partners. The NIS-Teen provides national and state estimates of vaccination coverage, including new vaccines as they are licensed and recommended for use. It also helps track progress towards the Healthy People 2020 goals.

What adolescents were included in the 2014 NIS-Teen?
The survey assessed the immunization histories of nearly 21,000 adolescents aged 13-17 years in the US. These adolescents were born between January 1996 and February 2002. In Texas, 1,652 adolescents were surveyed for the 2014 NIS-Teen.

What vaccines were included in the 2014 NIS-Teen?
The following vaccine doses routinely recommended for adolescents were measured in the 2014 NIS-Teen.

  • ≥1 Tetanus and diphtheria toxoids (Td) vaccine, or Tdap, or tetanus-unknown vaccine on or after age 10 years.
  • ≥1 dose of MenACWY or meningococcal-unknown type vaccine.
  • ≥1 dose of HPV vaccine, either quadrivalent or bivalent. Percentage reported among females and males separately.
  • ≥2 doses of HPV vaccine, either quadrivalent or bivalent. Percentage reported among females and males separately.
  • ≥3 doses of HPV vaccine, either quadrivalent or bivalent. Percentage reported among females and males separately.
  • HPV vaccine 3 dose series completion (among those initiating series). Percentage reported among females and males separately.

The NIS-Teen also measures coverage for the following catchup-schedule vaccines:

  • ≥2 doses of measles, mumps, and rubella (MMR) vaccine
  • ≥3 doses of hepatitis B vaccine
  • ≥2 doses of varicella (Chickenpox) vaccine

◆ NIS-Teen Table

Vaccination Coverage Levels in Texas and US – NIS-Teen

Vaccine

Texas 2013

Texas 2014

2013 to 2014
Texas Change
(+/-)

U.S. National
Average 2014

≥1 dose Tdap

84.3%

88.2%

+3.9

87.6%

≥1 dose MenACWY

85.5%

88.6%

+3.1

79.3%

≥1 dose HPV vaccine, Females

55.5%

50.7%

-4.8

60.0%

≥1 dose HPV vaccine, Males

33.7%

36.6%

+2.9

41.7%

≥3 doses HPV vaccine, Females

37.8%

33.9%

-3.9

39.7%

≥3 doses HPV vaccine, Males

14.9%

17.7%

+2.8

21.6%

◆ NIS-Teen Graph

Nis2014Teen


▲ Back to Top



View the National Immunization Surveys for:
2013 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |


Back to Immunization Coverage homepage

Last updated December 4, 2015